Treatment of cognitive impairment using specific α7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors

摘要

A method for improving cognition comprising administering to a patient (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide or a pharmaceutically acceptable salt thereof and an acetylcholinesterase inhibitor is described together with related compositions.